How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation

Daniela Romualdi; Simona De Cicco; D Gagliano; M Busacca; G Campagna; Antonio Lanzone; Maurizio Guido

doi:10.2337/dc12-2071

How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation

Daniela Romualdi^*, Simona De Cicco, D Gagliano, M Busacca, G Campagna, Antonio Lanzone, Maurizio Guido

^*Autore corrispondente per questo lavoro

IRCCS Oasi Maria SS. - Troina (EN)

Risultato della ricerca: Contributo in rivista › Articolo

10 Citazioni (Scopus)

Abstract

Metformin has been reported to reduce the risk of gestational diabetes (GD) in women with polycystic ovarian syndrome (PCOS). However, little is known about the mechanisms of action of this drug during pregnancy. In the attempt to fill this gap, we performed a prospective longitudinal study providing a detailed examination of glucose and insulin metabolism in pregnant women with PCOS undergoing metformin therapy.

Lingua originale	Inglese
pagine (da-a)	1477-1482
Numero di pagine	6
Rivista	Diabetes Care
Volume	36
Numero di pubblicazione	6
DOI	https://doi.org/10.2337/dc12-2071
Stato di pubblicazione	Pubblicato - 2013
Pubblicato esternamente	Sì

All Science Journal Classification (ASJC) codes

Medicina Interna
Endocrinologia, Diabete e Metabolismo
Infermieristica Avanzata e Specializzata

Keywords

Adolescent
Adult
Female
Humans
Hypoglycemic Agents
Insulin
Metformin
Polycystic Ovary Syndrome
Pregnancy
Pregnancy Trimesters
Prospective Studies
Young Adult

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.2337/dc12-2071

Altri file e collegamenti

Cita questo

@article{487fa1d9271e44f0ac83ac88d524785d,

title = "How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation",

abstract = "Metformin has been reported to reduce the risk of gestational diabetes (GD) in women with polycystic ovarian syndrome (PCOS). However, little is known about the mechanisms of action of this drug during pregnancy. In the attempt to fill this gap, we performed a prospective longitudinal study providing a detailed examination of glucose and insulin metabolism in pregnant women with PCOS undergoing metformin therapy.",

keywords = "Adolescent, Adult, Female, Humans, Hypoglycemic Agents, Insulin, Metformin, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Trimesters, Prospective Studies, Young Adult, Adolescent, Adult, Female, Humans, Hypoglycemic Agents, Insulin, Metformin, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Trimesters, Prospective Studies, Young Adult",

author = "Daniela Romualdi and {De Cicco}, Simona and D Gagliano and M Busacca and G Campagna and Antonio Lanzone and Maurizio Guido",

year = "2013",

doi = "10.2337/dc12-2071",

language = "English",

volume = "36",

pages = "1477--1482",

journal = "Diabetes Care",

issn = "1935-5548",

publisher = "American Diabetes Association:National Service Center, 1701 North Beaureguard Street:Alexandria, VA 22311:(800)232-3472, (703)549-1500, INTERNET: http://www.diabetes.org/diabetscare, Fax: (703)549-6995",

number = "6",

}

TY - JOUR

T1 - How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation

AU - Romualdi, Daniela

AU - De Cicco, Simona

AU - Gagliano, D

AU - Busacca, M

AU - Campagna, G

AU - Lanzone, Antonio

AU - Guido, Maurizio

PY - 2013

Y1 - 2013

N2 - Metformin has been reported to reduce the risk of gestational diabetes (GD) in women with polycystic ovarian syndrome (PCOS). However, little is known about the mechanisms of action of this drug during pregnancy. In the attempt to fill this gap, we performed a prospective longitudinal study providing a detailed examination of glucose and insulin metabolism in pregnant women with PCOS undergoing metformin therapy.

AB - Metformin has been reported to reduce the risk of gestational diabetes (GD) in women with polycystic ovarian syndrome (PCOS). However, little is known about the mechanisms of action of this drug during pregnancy. In the attempt to fill this gap, we performed a prospective longitudinal study providing a detailed examination of glucose and insulin metabolism in pregnant women with PCOS undergoing metformin therapy.

KW - Adolescent

KW - Adult

KW - Female

KW - Humans

KW - Hypoglycemic Agents

KW - Insulin

KW - Metformin

KW - Polycystic Ovary Syndrome

KW - Pregnancy

KW - Pregnancy Trimesters

KW - Prospective Studies

KW - Young Adult

KW - Adolescent

KW - Adult

KW - Female

KW - Humans

KW - Hypoglycemic Agents

KW - Insulin

KW - Metformin

KW - Polycystic Ovary Syndrome

KW - Pregnancy

KW - Pregnancy Trimesters

KW - Prospective Studies

KW - Young Adult

UR - https://publicatt.unicatt.it/handle/10807/53318

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84878225400&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84878225400&origin=inward

U2 - 10.2337/dc12-2071

DO - 10.2337/dc12-2071

M3 - Article

SN - 1935-5548

VL - 36

SP - 1477

EP - 1482

JO - Diabetes Care

JF - Diabetes Care

IS - 6

ER -

How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation

Abstract

All Science Journal Classification (ASJC) codes

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo